FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007648314> ?p ?o ?g. }

• W2007648314 endingPage "33" @default.
• W2007648314 startingPage "28" @default.
• W2007648314 abstract "Previous studies showed that mitoxantrone can reduce disability progression in patients with multiple sclerosis (MS). There is, however, concern that it may cause irreversible cardiomyopathy with reduced left ventricular (LV) ejection fraction (EF) and congestive heart failure. The aim of this prospective study was to investigate cardiac side effects of mitoxantrone by repetitive cardiac monitoring in MS patients. The treatment protocol called for ten courses of a combined mitoxantrone (10 mg/m² body surface) and methylprednisolone therapy. Before each course, a transthoracic echocardiogram was performed to determine the LV end-diastolic diameter, the end-systolic diameter and the fractional shortening; the LV-EF was calculated. Seventy-three patients participated (32 males; age 48 ± 12 years, range 20–75 years; 25 with primary progressive, 47 with secondary progressive and 1 with relapsing-remitting MS) who received at least four courses of mitoxantrone. Three of the 73 patients were excluded during the study (2 patients discontinued therapy; 1 patient with a previous history of ischemic heart disease developed atrial fibrillation after the second course of mitoxantrone). The mean cumulative dose of mitoxantrone was 114.0 ± 33.8 mg. The mean follow-up time was 23.4 months (range 10–57 months). So far, there has been no significant change in any of the determined parameters (end-diastolic diameter, end-systolic diameter, fractional shortening, EF) over time during all follow-up investigations. Mitoxantrone did not cause signs of congestive heart failure in any of the patients. Further cardiac monitoring is, however, needed to determine the safety of mitoxantrone after longer follow-up times and at higher cumulative doses." @default.
• W2007648314 created "2016-06-24" @default.
• W2007648314 creator A5003281614 @default.
• W2007648314 creator A5028689651 @default.
• W2007648314 creator A5060650180 @default.
• W2007648314 creator A5061687105 @default.
• W2007648314 creator A5078660065 @default.
• W2007648314 creator A5084013056 @default.
• W2007648314 creator A5084628427 @default.
• W2007648314 date "2005-01-01" @default.
• W2007648314 modified "2023-09-24" @default.
• W2007648314 title "Assessment of Potential Cardiotoxic Side Effects of Mitoxantrone in Patients with Multiple Sclerosis" @default.
• W2007648314 cites W1464796257 @default.
• W2007648314 cites W1967612576 @default.
• W2007648314 cites W1968176639 @default.
• W2007648314 cites W1995369846 @default.
• W2007648314 cites W2001050980 @default.
• W2007648314 cites W2012054969 @default.
• W2007648314 cites W2013769366 @default.
• W2007648314 cites W2024466455 @default.
• W2007648314 cites W2025419629 @default.
• W2007648314 cites W2033292054 @default.
• W2007648314 cites W2042426894 @default.
• W2007648314 cites W2042983418 @default.
• W2007648314 cites W2049065473 @default.
• W2007648314 cites W2060485000 @default.
• W2007648314 cites W2062576060 @default.
• W2007648314 cites W2065875085 @default.
• W2007648314 cites W2066919456 @default.
• W2007648314 cites W2079367120 @default.
• W2007648314 cites W2081592657 @default.
• W2007648314 cites W2101674248 @default.
• W2007648314 cites W2105490558 @default.
• W2007648314 cites W2112165124 @default.
• W2007648314 cites W2119172537 @default.
• W2007648314 cites W2130355701 @default.
• W2007648314 cites W2144633544 @default.
• W2007648314 cites W2149964703 @default.
• W2007648314 doi "https://doi.org/10.1159/000087242" @default.
• W2007648314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16088176" @default.
• W2007648314 hasPublicationYear "2005" @default.
• W2007648314 type Work @default.
• W2007648314 sameAs 2007648314 @default.
• W2007648314 citedByCount "28" @default.
• W2007648314 countsByYear W20076483142012 @default.
• W2007648314 countsByYear W20076483142013 @default.
• W2007648314 countsByYear W20076483142014 @default.
• W2007648314 countsByYear W20076483142015 @default.
• W2007648314 countsByYear W20076483142018 @default.
• W2007648314 countsByYear W20076483142020 @default.
• W2007648314 countsByYear W20076483142022 @default.
• W2007648314 crossrefType "journal-article" @default.
• W2007648314 hasAuthorship W2007648314A5003281614 @default.
• W2007648314 hasAuthorship W2007648314A5028689651 @default.
• W2007648314 hasAuthorship W2007648314A5060650180 @default.
• W2007648314 hasAuthorship W2007648314A5061687105 @default.
• W2007648314 hasAuthorship W2007648314A5078660065 @default.
• W2007648314 hasAuthorship W2007648314A5084013056 @default.
• W2007648314 hasAuthorship W2007648314A5084628427 @default.
• W2007648314 hasBestOaLocation W20076483142 @default.
• W2007648314 hasConcept C118552586 @default.
• W2007648314 hasConcept C126322002 @default.
• W2007648314 hasConcept C151032500 @default.
• W2007648314 hasConcept C164705383 @default.
• W2007648314 hasConcept C2776694085 @default.
• W2007648314 hasConcept C2778198053 @default.
• W2007648314 hasConcept C2778797674 @default.
• W2007648314 hasConcept C2779161974 @default.
• W2007648314 hasConcept C2780640218 @default.
• W2007648314 hasConcept C2780923524 @default.
• W2007648314 hasConcept C57900726 @default.
• W2007648314 hasConcept C71924100 @default.
• W2007648314 hasConcept C78085059 @default.
• W2007648314 hasConcept C84393581 @default.
• W2007648314 hasConceptScore W2007648314C118552586 @default.
• W2007648314 hasConceptScore W2007648314C126322002 @default.
• W2007648314 hasConceptScore W2007648314C151032500 @default.
• W2007648314 hasConceptScore W2007648314C164705383 @default.
• W2007648314 hasConceptScore W2007648314C2776694085 @default.
• W2007648314 hasConceptScore W2007648314C2778198053 @default.
• W2007648314 hasConceptScore W2007648314C2778797674 @default.
• W2007648314 hasConceptScore W2007648314C2779161974 @default.
• W2007648314 hasConceptScore W2007648314C2780640218 @default.
• W2007648314 hasConceptScore W2007648314C2780923524 @default.
• W2007648314 hasConceptScore W2007648314C57900726 @default.
• W2007648314 hasConceptScore W2007648314C71924100 @default.
• W2007648314 hasConceptScore W2007648314C78085059 @default.
• W2007648314 hasConceptScore W2007648314C84393581 @default.
• W2007648314 hasIssue "1" @default.
• W2007648314 hasLocation W20076483141 @default.
• W2007648314 hasLocation W20076483142 @default.
• W2007648314 hasLocation W20076483143 @default.
• W2007648314 hasOpenAccess W2007648314 @default.
• W2007648314 hasPrimaryLocation W20076483141 @default.
• W2007648314 hasRelatedWork W1949634191 @default.
• W2007648314 hasRelatedWork W2059312764 @default.
• W2007648314 hasRelatedWork W2150788839 @default.
• W2007648314 hasRelatedWork W2312948512 @default.

• next